Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 63

1.

BCL2L12 protein overexpression is associated with favorable outcome in diffuse large B-cell lymphoma patients in the rituximab era.

Papageorgiou SG, Kontos CK, Foukas PG, Panopoulou E, Vasilatou D, Rapti SM, Gkontopoulos K, Bazani E, Panayiotides IG, Dimitriadis G, Scorilas A, Pappa V.

Leuk Lymphoma. 2016 Sep;57(9):2199-203. doi: 10.3109/10428194.2015.1126588. Epub 2016 Jan 14. No abstract available.

PMID:
27442703
2.

Identification of novel alternative splice variants of the BCL2L12 gene in human cancer cells using next-generation sequencing methodology.

Adamopoulos PG, Kontos CK, Tsiakanikas P, Scorilas A.

Cancer Lett. 2016 Apr 1;373(1):119-129. doi: 10.1016/j.canlet.2016.01.019. Epub 2016 Jan 18.

PMID:
26797417
3.

Differential roles of Bcl2L12 and its short variant in breast cancer lymph node metastasis.

Chien ST, Yang TF, Yang MC, Hsu CM, Hong YR, Lee TM.

Oncol Rep. 2015 Aug;34(2):961-71. doi: 10.3892/or.2015.4071. Epub 2015 Jun 16.

PMID:
26082034
4.

Bcl2L12 with a BH3-like domain in regulating apoptosis and TMZ-induced autophagy: a prospective combination of ABT-737 and TMZ for treating glioma.

Yang MC, Loh JK, Li YY, Huang WS, Chou CH, Cheng JT, Wang YT, Lieu AS, Howng SL, Hong YR, Chou AK.

Int J Oncol. 2015 Mar;46(3):1304-16. doi: 10.3892/ijo.2015.2838. Epub 2015 Jan 13.

PMID:
25586056
5.

BCL2L12: a promising molecular prognostic biomarker in breast cancer.

Tzovaras A, Kladi-Skandali A, Michaelidou K, Zografos GC, Missitzis I, Ardavanis A, Scorilas A.

Clin Biochem. 2014 Dec;47(18):257-62. doi: 10.1016/j.clinbiochem.2014.09.008. Epub 2014 Sep 16.

PMID:
25230343
7.

[Expression of BCL2L12 gene in de novo acute myeloid leukemia and its clinical implications].

Yu MX, Lu Y, Mu QT, Wang Q, Chen ZM, Lou JY, Jin J.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2013 Oct;30(5):544-8. doi: 10.3760/cma.j.issn.1003-9406.2013.05.008. Chinese.

PMID:
24078567
8.

Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma.

Gartner JJ, Parker SC, Prickett TD, Dutton-Regester K, Stitzel ML, Lin JC, Davis S, Simhadri VL, Jha S, Katagiri N, Gotea V, Teer JK, Wei X, Morken MA, Bhanot UK; NISC Comparative Sequencing Program, Chen G, Elnitski LL, Davies MA, Gershenwald JE, Carter H, Karchin R, Robinson W, Robinson S, Rosenberg SA, Collins FS, Parmigiani G, Komar AA, Kimchi-Sarfaty C, Hayward NK, Margulies EH, Samuels Y.

Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13481-6. doi: 10.1073/pnas.1304227110. Epub 2013 Jul 30. Erratum in: Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):563.

9.

Increased BCL2L12 expression predicts the short-term relapse of patients with TaT1 bladder cancer following transurethral resection of bladder tumors.

Foutadakis S, Avgeris M, Tokas T, Stravodimos K, Scorilas A.

Urol Oncol. 2014 Jan;32(1):39.e29-36. doi: 10.1016/j.urolonc.2013.04.005. Epub 2013 Jun 18.

PMID:
23790536
10.

Cisplatin downregulates BCL2L12, a novel apoptosis-related gene, in glioblastoma cells.

Taghavi MS, Akbarzadeh A, Mahdian R, Azadmanesh K, Javadi G.

In Vitro Cell Dev Biol Anim. 2013 Jun;49(6):465-72. doi: 10.1007/s11626-013-9622-4. Epub 2013 May 25.

PMID:
23708917
11.

Expression of Bcl2L12 in chronic lymphocytic leukemia patients: association with clinical and molecular prognostic markers.

Karan-Djurasevic T, Palibrk V, Zukic B, Spasovski V, Glumac I, Colovic M, Colovic N, Jurisic V, Scorilas A, Pavlovic S, Tosic N.

Med Oncol. 2013 Mar;30(1):405. doi: 10.1007/s12032-012-0405-7. Epub 2013 Jan 5.

PMID:
23292833
12.

Quantitative expression analysis of the apoptosis-related gene, BCL2L12, in head and neck squamous cell carcinoma.

Geomela PA, Kontos CK, Yiotakis I, Scorilas A.

J Oral Pathol Med. 2013 Feb;42(2):154-61. doi: 10.1111/j.1600-0714.2012.01190.x. Epub 2012 Jul 2.

PMID:
22747515
13.

Overexpression of the novel member of the BCL2 gene family, BCL2L12, is associated with the disease outcome in patients with acute myeloid leukemia.

Thomadaki H, Floros KV, Pavlovic S, Tosic N, Gourgiotis D, Colovic M, Scorilas A.

Clin Biochem. 2012 Nov;45(16-17):1362-7. doi: 10.1016/j.clinbiochem.2012.06.012. Epub 2012 Jun 19.

PMID:
22728012
14.

Molecular cloning of novel alternatively spliced variants of BCL2L12, a new member of the BCL2 gene family, and their expression analysis in cancer cells.

Kontos CK, Scorilas A.

Gene. 2012 Aug 15;505(1):153-66. doi: 10.1016/j.gene.2012.04.084. Epub 2012 Jun 1.

PMID:
22664385
15.

The role of Bcl-2 family proteins in therapy responses of malignant astrocytic gliomas: Bcl2L12 and beyond.

Kouri FM, Jensen SA, Stegh AH.

ScientificWorldJournal. 2012;2012:838916. doi: 10.1100/2012/838916. Epub 2012 Feb 14. Review.

16.
17.

The novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker.

Papageorgiou SG, Kontos CK, Pappa V, Thomadaki H, Kontsioti F, Dervenoulas J, Papageorgiou E, Economopoulos T, Scorilas A.

Oncologist. 2011;16(9):1280-91. doi: 10.1634/theoncologist.2010-0349. Epub 2011 Jul 7.

18.

Beyond effector caspase inhibition: Bcl2L12 neutralizes p53 signaling in glioblastoma.

Stegh AH, DePinho RA.

Cell Cycle. 2011 Jan 1;10(1):33-8. Epub 2011 Jan 1. Review.

19.

BCL2L12 is a novel biomarker for the prediction of short-term relapse in nasopharyngeal carcinoma.

Fendri A, Kontos CK, Khabir A, Mokdad-Gargouri R, Scorilas A.

Mol Med. 2011 Mar-Apr;17(3-4):163-71. doi: 10.2119/molmed.2010.00056. Epub 2010 Dec 8.

20.

Molecular analysis and prognostic impact of the novel apoptotic gene BCL2L12 in gastric cancer.

Florou D, Papadopoulos IN, Scorilas A.

Biochem Biophys Res Commun. 2010 Jan 1;391(1):214-8. doi: 10.1016/j.bbrc.2009.11.034. Epub 2009 Nov 10.

PMID:
19903463

Supplemental Content

Support Center